With the possibility of military action against Syria easing, investors sent the markets soaring to a sharply higher close with the Dow leaping 127 points to 15,191. Nasdaq climbed 22 points to 3729.
On the upside
United Airlines (NYSE: UAL) reported that August 2013 consolidated passenger revenue per available seat mile increased between 3.5% to 4.5% from August 2012.
SunEdison (NYSE: SUNE) closed a $212.5 million financing arrangement to fund construction of a 100MWp solar power plant in Chile.
NanoString Technologies (Nasdaq: NSTG) received 510(k) clearance from the Food and Drug Administration for its Prosigna Breast Cancer Prognostic Gene Signature Assay.
On the downside
ChemoCentryx (Nasdaq: CCXI) reported interim data from a Phase II clinical trial of its diabetic nephropathy treatment CCX140.
Investors locked in profits on Myriad Genetics (Nasdaq: MYGN).
Peregrine Pharmaceuticals (Nasdaq: PPHM) reported a loss for the first quarter.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by a margin of nearly 2 to 1 on Nasdaq. The broader S&P 500 climbed 12 points to 1683.
